M. Akdogan Et Al. , "The safety and effectiveness of 0.16 mg bevacizumab plus or minus additional laser photocoagulation in the treatment of retinopathy of prematurity," INDIAN JOURNAL OF OPHTHALMOLOGY , vol.67, no.6, pp.879-883, 2019
Akdogan, M. Et Al. 2019. The safety and effectiveness of 0.16 mg bevacizumab plus or minus additional laser photocoagulation in the treatment of retinopathy of prematurity. INDIAN JOURNAL OF OPHTHALMOLOGY , vol.67, no.6 , 879-883.
Akdogan, M., Cevik, S. G., & ŞAHİN, Ö., (2019). The safety and effectiveness of 0.16 mg bevacizumab plus or minus additional laser photocoagulation in the treatment of retinopathy of prematurity. INDIAN JOURNAL OF OPHTHALMOLOGY , vol.67, no.6, 879-883.
Akdogan, Muberra, Sadik Gorkem Cevik, And ÖZLEM ŞAHİN. "The safety and effectiveness of 0.16 mg bevacizumab plus or minus additional laser photocoagulation in the treatment of retinopathy of prematurity," INDIAN JOURNAL OF OPHTHALMOLOGY , vol.67, no.6, 879-883, 2019
Akdogan, Muberra Et Al. "The safety and effectiveness of 0.16 mg bevacizumab plus or minus additional laser photocoagulation in the treatment of retinopathy of prematurity." INDIAN JOURNAL OF OPHTHALMOLOGY , vol.67, no.6, pp.879-883, 2019
Akdogan, M. Cevik, S. G. And ŞAHİN, Ö. (2019) . "The safety and effectiveness of 0.16 mg bevacizumab plus or minus additional laser photocoagulation in the treatment of retinopathy of prematurity." INDIAN JOURNAL OF OPHTHALMOLOGY , vol.67, no.6, pp.879-883.
@article{article, author={Muberra Akdogan Et Al. }, title={The safety and effectiveness of 0.16 mg bevacizumab plus or minus additional laser photocoagulation in the treatment of retinopathy of prematurity}, journal={INDIAN JOURNAL OF OPHTHALMOLOGY}, year=2019, pages={879-883} }